Regional Burn Director

The Regional Burn Director is responsible for working cross-functionally to create effective training and sales strategies that position Kerecis Omega3 Burn competitively in the market and increase sales. The Director will work closely with the field sales team to educate them on proper usage and promotion of Kerecis burn products. The Director will frequently visit accounts to attend burn product applications and provide education. This is a full-time position.

The Regional Burn Director reports to the Executive Vice President of Commercial Operations and works in the assigned Territory (defined below).

Essential Functions

• Position Kerecis competitively in the burn / traumatic injury market and increase sales
• Develop, sell, in-service Kerecis burn accounts within the Territory (defined below), and other areas of the United States, as necessary
• Educate the burn community on the benefits of Kerecis Omega3 Burn
• Attend all burn related meetings
• Manage approved operating budget per month
• Travel as necessary to all targeted burn accounts for in-servicing, education and applications
• Manage the ordering process and inventory for burn accounts
• Work strategically with Regional Directors to create new opportunities in their regions
• Work with the Medical Affairs team to develop a Burn Advisory Committee, Burn Center of Excellence, Burn KOL Development, Burn Abstracts / Studies and other burn related initiatives
• Assist in the training and development of Kerecis Business Development Managers to be proficient in burn product applications
• Conduct burn training for Kerecis staff as necessary
• Assist the marketing and sales teams to develop a successful Burn sales strategy
• Meet the established new business quota
• Work with Strategic Accounts to develop a strong economic model, box pricing and a total solutions model for committed burn customers

Secondary Functions

• Provide innovative solutions to problems
• Maintain utmost integrity in all aspects of the job
• Be a team player

Anticipated travel: 85%